News

Tenovi announces the launch of a consumer-focused campaign giving Medicare-eligible patients and caregivers the opportunity ...
It said that 95% of people with cystic fibrosis in England will now be eligible for modulator therapy. The new drug, also ...
(NewsUSA) - A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or burdens of current treatments.A Small Pill With Big Potential ...
(NewsUSA) - A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or burdens of current treatments.A Small Pill With Big Potential If you ...
With these Wirecutter-approved picks under $100, you don’t have to spend a lot to get a good deal this Amazon Prime Day.